89 active shortage notices across 13 countries · 7 anticipated.
Last updated 2 Aug 2026 · sourced from official medicines regulators
| Germany | high | 8 | 28 Mar 2025 | 31 Dec 2026 | BfArM |
| United States | high | 5 | 16 Mar 2023 | — | FDA MedWatch |
| New Zealand | high | 2 | 16 Jan 2026 | — | Pharmac |
| Italy | medium | 19 | 15 Jun 2024 | 31 Dec 2026 | AIFA |
| Canada | medium | 18 | 29 Jun 2016 | 1 Jun 2027 | HC |
| Netherlands | medium | 6 | 16 Mar 2026 | — | CBG-MEB |
| Belgium | medium | 5 | 10 Mar 2026 | 7 Oct 2026 | FAMHP |
| Ireland | medium | 4 | 14 Mar 2025 | 7 May 2026 | HPRA |
| Bosnia and Herzegovina | medium | 3 | 31 Jul 2025 | 31 Dec 2026 | ALMBIH |
| India | medium | 2 | 1 May 2026 | — | CDSCO |
| Greece | medium | 2 | 22 Dec 2025 | — | EOF |
| Spain | medium | 1 | 7 Apr 2026 | 3 Jun 2026 | AEMPS |
Clinically related options from Mederti's curated alternatives data. Always confirm suitability with a pharmacist or prescriber before substituting.
Yes. As of the latest regulator updates, Atorvastatin has 89 active shortage notices across 13 countries (Australia, Germany, United States, New Zealand, Italy, Canada and more). Status is refreshed daily from official regulatory sources.
Regulators attribute the current Atorvastatin shortages to causes not stated by the regulator, manufacturing problems, raw-material (API) supply problems. The exact cause varies by country and product — each notice on this page links to the official source.
Regulator-estimated resolution dates currently range from 20 Feb 2026 to 1 Jun 2027, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.
Mederti lists 2 clinically related alternatives for Atorvastatin (see the alternatives section above). Alternatives require clinical judgement — always confirm suitability with a pharmacist or prescriber and your national guidance before substituting.
Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.
Colestipol Hydrochloride · Fenofibrato · Ezetimib · Ezetimiba Viatris · Fenofibrate · Atorvastatin 80 Mg Film-Coated Tablets (Atorvastatin)
Free for individual pharmacists and clinicians — watchlists, email alerts, alternatives and country-by-country product detail.
Create a free accountData on this page is aggregated from official national medicines regulators and updated daily. It is provided for information only and requires verification before clinical use. Mederti is not affiliated with or endorsed by any regulator.